About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

TERMINATEDNCT01311128

Determination of the Accuracy of a Non-Invasive Continuous Blood Pressure Device

This protocol will test a new non-invasive device, the T-line, in continuously determining heart rate and blood pressure in operative and critically ill patients. The accuracy of the device will be co...

Lead sponsor: Oregon Health and Science University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Oregon Health and Science University

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Age at least 18 years old
•Operative patients expected to require intensive care recovery at OHSU
•Planned or existing intra- and postoperative radial artery catheterization as part of routine care
•Palpable contralateral (to catheter) radial artery pulse
•Planned intraoperative right heart catheter placement as part of routine clinical care, in at least 20 subjects of total

Exclusion Criteria

•No palpable radial artery pulse
•Anatomical abnormalities (skin grafts, cysts, cellulitis) or injuries (scarring, cuts, burns, bruising) at the sensor site
•An intravenous line placed at the sensor application site or within the medial/lateral travel range of the sensor
•An AV shunt in the T-line arm
•Known sensitivity to pressure stimuli (dermatographism)

Related studies

RECRUITINGPhase 4

Effects of Donor-recipient Sex-matched Blood Transfusion on Patient Outcomes

NCT06840756 · Red Blood Cell Transfusions, Sex Differences, and more

Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit

NCT07448805 · Diabetes Mellitus, Blood Sugar, and more

Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients

NCT07222007 · Critically Ill, Intubation Complication, and more

Quality Improvement Intervention for a Safe Antimicrobial Use Reduction in Critically Ill Patients

NCT07093450 · Infection, Antimicrobial Stewardship, and more

Parasternal Intercostal Muscle Thickening as an Additive Weaning Criterion

NCT07143695 · Critically Ill

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 28, 2019Terms

Trial snapshot

StatusTERMINATED

Phase—

Enrollment31

Start dateFeb 2011

Last updatedAug 28, 2019

Condition

Locations shown

Oregon Health & Science University

Portland, Oregon

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 28, 2019Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions